TABLE 3:

Psychometric test scores of patients with sickle cell disease stratified by hematocrit

ComparisonHematocrit ≥ 27Hematocrit < 27ΔPooled t test P <
No.Mean ± SDNo.Mean ± SD
Mean hematocrit1729.2 ± 3.22821.4 ± 3.7−26.7%0.0001
Full-scale IQ1786.0 ± 13.82876.9 ± 11.3−10.6%0.006
 WISC-R FSIQ690.5 ± 9.0982.0 ± 8.1−9.4%0.04
 WISC-III FSIQ1183.5 ± 12.41974.5 ± 12.0−10.8%0.03
  Verbal IQ1187.1 ± 12.51977.1 ± 12.9−11.5%0.02
  Performance IQ1182.7 ± 12.61976.2 ± 12.2−7.9%NS
WISC-III factor scores
 VC factor1089.9 ± 13.41977.0 ± 11.7−14.3%0.006
 PO factor1184.0 ± 13.71975.8 ± 12.9−9.8%NS
 FD factor1096.2 ± 12.11985.3 ± 13.3−11.3%0.02
 PS factor1088.6 ± 11.71887.7 ± 18.5−1.0%NS
  • Note.—IQ indicates intelligence quotient; WISC-R (FSIQ), Wechsler Intelligence Scales for Children-Revised full-scale intelligence quotient; WISC-III FSIQ, Wechsler Intelligence Scales for Children-Version III full-scale intelligence quotient; VC, verbal comprehension; PO, perceptual organization; FD, freedom from distractibility; PS, processing speed; NS, not significant. When hematocrit was used to partition patients into those with low hematocrit values (<27) and those with more normal hematocrit values (≥27), significant differences in psychometric test scores were observed: The Δ value was calculated as the percent reduction in the comparison value in the low hematocrit group, compared with the value in the more normal hematocrit group. A one-way pooled t test was used to test for significance because of a prediction that patients with low hematocrit would have lower psychometric test scores. Patients with low hematocrit were not significantly younger than patients with more normal hematocrit (9.6 versus 9.4 years, P = .43).